Researchers are continuing to study nasopharyngeal carcinoma (NPC) to understand how it develops and what it responds to. Their goal is to provide better outcomes and possible prevention. NPC is a ...
A novel biomarker derived from Epstein-Barr virus (EBV) significantly improved the diagnostic accuracy for nasopharyngeal carcinoma, a large screening study from China showed. Screening with P85-Ab, ...
In a phase 3 trial, toripalimab-based chemotherapy with radiotherapy without concurrent cisplatin achieved noninferior 3-year failure-free survival compared with standard therapy in patients with ...
SHANGHAI, Oct. 24, 2025 /PRNewswire/ -- At 15:00 Beijing Time (09:00 am Berlin Time) on October 20, the "Global Launch Event for Iza-bren (EGFR×HER3 Bispecific ADC) Nasopharyngeal Carcinoma ...
Health Canada has approved a new treatment for adults with recurrent or metastatic nasopharyngeal carcinoma, a rare form of head and neck cancer, the company behind the treatment said in a statement ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback